• Info
  • Insider Ownership

Insider Trading & Ownership of Frank Mccormick

Location
San Francisco, CA
Summary
The estimated net worth of Frank Mccormick is at least $51,404,193 dollars as of 31 Oct 2025. Frank Mccormick is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $51.4M.
Signature
/s/ Will Solis, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Frank Mccormick and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Frank Mccormick has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $51,404,193.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BridgeBio Pharma, Inc. ($51,404,193).
  • Past-year value change for that position: -$21,669,537.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Frank Mccormick

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. Director $51,404,193 -$21,669,537 -30% 29 Oct 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Director 26 Aug 2025

Insider Transactions Reported by Frank Mccormick:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored